Rituximab Maintenance After Autologous Transplantation

Summary

The goal of this clinical research is to see if Rituxan (rituximab) therapy given after high dose chemotherapy and transplant of a patients own stem cells will prevent or delay the return of the lymphoma.

Timeline

Start

2003-08

Primary completion

2006-04

Completion

2010-04

Outcome

Outcome not reported

Stopped (Enrollment): “Closed early due to slow patient accrual and sponsor's withdrawal of support.”

Drugs

Indications